Free Cash Flow

FibroGen Inc (FGEN)

$ 18.57
-0.24 (-1.28%)

Free Cash Flow

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 102.17137.60180.83179.58125.67212.96256.58176.32200.01226.88257.36291.93331.16
Revenue (%)
Operating Cash Flow 25.9222.41-18.577.11-66.51-76.14-78.7181.60-9.43-10.70-12.14-13.77-15.62
Operating Cash Flow (%)
Capital Expenditure -6.81-8.12-1.98-1.25-8.50-8.02-5.76-3.99-7.35-8.34-9.46-10.73-12.17
Capital Expenditure (%)
Free Cash Flow 19.1114.30-20.555.86-75.01-84.16-84.4777.61-16.78-19.04-21.59-24.50-27.79

FCF Unlevered from cash flow statement